Finance

Lists
Why is OKUR down २.२७%?
Dive Deeper
OKUR:NASDAQ
Onkure Therapeutics Inc
US$ २.३६
-२.२७%
(-०.०५५) 1D
अक्टोबर १३, १२:५३:३१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKUR...
Open
US$ २.४०
High
US$ २.४०
Low
US$ २.३१
Mkt. cap
९.५८ करोड
Avg. vol.
३.१९ लाख
Volume
१.१९ लाख
52-wk high
US$ ५.३८
52-wk low
US$ २.१३
EPS
-US$ ३.५०
Beta
०.१२
Shares outstanding
४.०५ करोड
No. of employees
४५
Open
US$ २.४०
High
US$ २.४०
Low
US$ २.३१
Mkt. cap
९.५८ करोड
Avg. vol.
३.१९ लाख
Volume
१.१९ लाख
52-wk high
US$ ५.३८
52-wk low
US$ २.१३
EPS
-US$ ३.५०
Beta
०.१२
Shares outstanding
४.०५ करोड
No. of employees
४५
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
१ घण्टा पहिले
Movado CEO Efraim Grinberg Reflects on 25 Years as a NYSE-Listed Company
JD Supra
JD Supra
·
१२ मिनेट पहिले
Nasdaq Files Proposed Rule Change Regarding the $5 Million MVLS Continued Listing Requirement Amid SEC Stay
The Seattle Times
The Seattle Times
·
५४ मिनेट पहिले
The first big batch of US profit reports for the summer has Wall Street mixed
CNBC
CNBC
·
२९ मिनेट पहिले
How options traders can prepare for a Nasdaq pullback
About Onkure Therapeutics Inc
CEO-
Employees४५
Founded२०११
Headquartersबोल्डर, कोलोराडो, संयुक्त राज्य अमेरिका
Sector-
Websiteonkuretherapeutics.com
Analyst ratings
Based on 4 analysts giving stock ratings to OKUR in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for OKUR in the last 3 months.
Highest
Current US$ २.३६
US$ २१.०० (+७८७.९५%)
Average
US$ १७.०० (+६१८.८२%)
Lowest
US$ १४.०० (+४९१.९७%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Biegler
Oppenheimer
Buy
Reiterated
US$ १४.००
+४९२%
08/14/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
US$ १४.००
+४९२%
08/14/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
US$ १६.००
+५७६.५%
08/05/2026
Boris Peaker
JonesTrading
Hold
Maintained
-
-
08/05/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
US$ २१.००
+७८७.९%
07/20/2026
Soumit Roy
JonesTrading
Buy
Maintained
US$ १७.००
+६१८.८%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१.१९ करोड
१.०७ करोड
१.१७ करोड
१.२६ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३५.८६ लाख
३४.०५ लाख
३९.०८ लाख
४२.८८ लाख
Operating expense
१.५५ करोड
१.४१ करोड
१.५६ करोड
१.६९ करोड
Total operating expenses
१.५५ करोड
१.४१ करोड
१.५६ करोड
१.६९ करोड
Operating income
-१.५५ करोड
-१.४१ करोड
-१.५६ करोड
-१.६९ करोड
Other non operating income
-
-
-
-
EBT including unusual items
-१.४७ करोड
-१.३५ करोड
-१.५२ करोड
-१.५३ करोड
EBT excluding unusual items
-१.४७ करोड
-१.३५ करोड
-१.५२ करोड
-१.५३ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१.४७ करोड
-१.३५ करोड
-१.५२ करोड
-१.५३ करोड
Net profit margin
-
-
-
-
Earnings per share
-१.०९
-०.९९
-१.११
-०.३१
Interest and investment income
८.०४ लाख
६.२८ लाख
४.५८ लाख
१५.५३ लाख
Interest expense
-२.०० हजार
-६.०० हजार
-
-
Net interest expenses
८.०२ लाख
६.२२ लाख
४.५८ लाख
१५.५३ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.५४ करोड
-१.४० करोड
-१.५५ करोड
-१.६८ करोड
Gain or loss from assets sale
२.०० हजार
४.०० हजार
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू